TickerFacts.

Curanex Pharmaceuticals Inc (CURX): Shareholders' Equity

Annual figures by period end, from SEC filings.

$11.22M
As of 2025-12-31
$4.79M
As of 2026-06-30
2024-12-31: $503.4K2025-12-31: $11.22M$11.22M
2024-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$11.22Mn/m2026-03-30, Balance as of period end
2024-12-31$503.4Kn/a2026-03-30, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Curanex Pharmaceuticals Inc (CURX)2025-12-31$11.22Mn/m
Revelation Biosciences, Inc. (REVB)2025-12-31$8.86M+88.2%
NewcelX Ltd. (NCEL)2025-12-31$7.25Mn/m
PRF Technologies Ltd. (PRFX)2025-12-31$8.54M+368.4%
MetaVia Inc. (MTVA)2025-12-31$5.33M-32.8%
Mira Pharmaceuticals, Inc. (MIRA)2025-12-31$10.39M+372.4%
Decoy Therapeutics Inc. (DCOY)2025-12-31$5.89M+289.6%
Anebulo Pharmaceuticals, Inc. (ANEB)2025-06-30$11.66M+205.8%
Lantern Pharma Inc. (LTRN)2025-12-31$6.53M-69.2%

Compare CURX, REVB, NCEL, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗